Liu F, Roth R A
Department of Pharmacology, Stanford University School of Medicine, CA 94305.
Biochem J. 1994 Mar 1;298 ( Pt 2)(Pt 2):471-7. doi: 10.1042/bj2980471.
A line of Chinese hamster ovary cells overexpressing protein kinase C alpha was transfected with cDNAs encoding either the wild-type human insulin receptor or one of two mutant insulin receptors with either Ser-967 and -968 or -974 and -976 in the juxtamembrane region changed to alanine. Both mutant receptors exhibited normal insulin-activated tyrosine kinase activity as assessed by either autophosphorylation or insulin-stimulated increases in anti-phosphotyrosine-precipitable phosphatidylinositol 3-kinase. The wild-type and mutant insulin receptors were also examined for serine and threonine phosphorylation in response to insulin and activation of protein kinase C. To visualize Ser/Thr-phosphorylation sites of the receptor better in response to insulin, the receptor from in vivo-labelled insulin-treated cells was first treated with a tyrosine-specific phosphatase to remove all tyrosine phosphorylation. Phosphopeptides from the three receptors were analysed by high-percentage polyacrylamide/urea gel electrophoresis and two-dimensional t.l.c. The mutant receptor lacking Ser-967 and -968 but not the mutant lacking Ser-974 and -976 was found to be missing phosphorylated peptides in response to insulin and, to a lesser extent, after activation of protein kinase C. However, the insulin-stimulated increase in anti-phosphotyrosine-precipitable phosphatidylinositol 3-kinase was inhibited to the same extent by activation of protein kinase C in cells expressing the two mutant receptors as in cells expressing the wild-type receptor. These results indicate that these four serine residues in the juxtamembrane region are not major regulatory sites of the intrinsic tyrosine kinase activity of the insulin receptor by protein kinase C, although Ser-967 and/or -968 appear to be phosphorylated in response to insulin.
用编码野生型人胰岛素受体或两种突变胰岛素受体之一的cDNA转染过表达蛋白激酶Cα的中国仓鼠卵巢细胞系,这两种突变胰岛素受体在近膜区的Ser-967和-968或-974和-976被替换为丙氨酸。通过自身磷酸化或胰岛素刺激的抗磷酸酪氨酸沉淀的磷脂酰肌醇3激酶增加评估,两种突变受体均表现出正常的胰岛素激活酪氨酸激酶活性。还检测了野生型和突变型胰岛素受体对胰岛素的丝氨酸和苏氨酸磷酸化以及蛋白激酶C的激活情况。为了更好地观察受体对胰岛素反应时的Ser/Thr磷酸化位点,先将体内标记胰岛素处理细胞的受体用酪氨酸特异性磷酸酶处理以去除所有酪氨酸磷酸化。通过高百分比聚丙烯酰胺/尿素凝胶电泳和二维薄层层析分析三种受体的磷酸肽。发现缺少Ser-967和-968的突变受体在对胰岛素反应时以及在较小程度上在蛋白激酶C激活后缺少磷酸化肽,但在表达两种突变受体的细胞中,蛋白激酶C激活对胰岛素刺激的抗磷酸酪氨酸沉淀的磷脂酰肌醇3激酶增加的抑制程度与表达野生型受体的细胞相同。这些结果表明,近膜区的这四个丝氨酸残基不是蛋白激酶C调节胰岛素受体内在酪氨酸激酶活性的主要位点,尽管Ser-967和/或-968似乎在对胰岛素反应时被磷酸化。